PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14712293-3	2004	Here, we describe the establishment and phenotypic characterization of U937 cells in which P210 BCR/ABL can be conditionally expressed using tetracycline.	Tetracycline	141-153	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	96-103	
16954505-8	2007	Tetracycline-inducible expression of KLF4 in B-cell progenitors of transgenic mice blocks transformation by BCR-ABL and depletes leukemic pre-B cells in vivo.	Tetracycline	0-12	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	108-115	
22169319-2	2011	To date, a number of BCR/ABL transgenic animal models have been established using different promoter or tetracycline-controlling system.	Tetracycline	104-116	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	21-28	
12821944-4	2003	The enforced expression of BCR-ABL in an ES cell line, engineered to express a tetracycline-inducible dominant-negative form of a STAT3, triggered ES cell differentiation with an increased generation of hematopoietic cells expressing erythroid and megakaryocytic phenotypes.	Tetracycline	79-91	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	27-34	
11526595-3	2001	A tetracycline-regulated promoter was developed to drive Bcr-Abl expression in differentiating embryonal stem cells.	Tetracycline	2-14	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	57-64	
12138893-4	2002	We have developed an in vitro system that mirrors the chronic phase of CML with a combination of in vitro embryonic stem cell differentiation and tetracycline-inducible Bcr-Abl expression.	Tetracycline	146-158	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	169-176	
11010972-5	2000	First, induction of BCR/ABL by a tetracycline-regulated promoter is associated with a reversible down-regulation of p27(Kip1).	Tetracycline	33-45	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	20-27	
10677527-6	2000	We utilized tetracycline-regulated expression of Bcr-Abl from a promoter engineered for robust expression in primitive stem cells through multilineage blood cell development in combination with the in vitro differentiation of embryonal stem cells into hematopoietic elements.	Tetracycline	12-24	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	49-56	
28024479-12	2016	Tetracycline induced its expression for 48 h and 72 h. pTER117, pTER363 decreased the mRNA level of BCR/ABL 90%, 82% and 91.5%, 84%, respectively, P210 protein were almost measured in K562 cells.	Tetracycline	0-12	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	100-107